Literature DB >> 27864618

Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer: methodological issues.

Nahid Karamzad1, Erfan Ayubi2, Vahid Rahmani3, Saeid Safiri4,5.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27864618     DOI： 10.1007/s00345-016-1974-4

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  3 in total

1.  Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study.

Authors:  Noriko Yoshimura; Shigeyuki Muraki; Hiroyuki Oka; Hiroshi Kawaguchi; Kozo Nakamura; Toru Akune
Journal:  J Rheumatol       Date:  2011-02-15       Impact factor: 4.666

2.  Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population.

Authors:  Erfan Ayubi; Davood Khalili; Ali Delpisheh; Farzad Hadaegh; Fereidoun Azizi
Journal:  J Diabetes       Date:  2015-02-19       Impact factor: 4.006

3.  Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer.

Authors:  Neil J Kocher; Chris Rjepaj; Haley Robyak; Erik Lehman; Jay D Raman
Journal:  World J Urol       Date:  2016-05-17       Impact factor: 4.226
  3 in total
  3 in total

1.  Comments on the association between reduced arterial stiffness and preserved diastolic function of the left ventricle in middle-aged and elderly patients.

Authors:  Saeid Safiri; Erfan Ayubi
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-10-25       Impact factor: 3.738

2.  Relationship between parental hypertension and cardiometabolic risk factors in adolescents: Methodological issues.

Authors:  Saeid Safiri; Erfan Ayubi
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-01       Impact factor: 3.738

3.  Characteristics and prognosis of primary treatment-naïve oral cavity squamous cell carcinoma in Norway, a descriptive retrospective study.

Authors:  Inger-Heidi Bjerkli; Olav Jetlund; Gunnhild Karevold; Ása Karlsdóttir; Ellen Jaatun; Lars Uhlin-Hansen; Oddveig G Rikardsen; Elin Hadler-Olsen; Sonja E Steigen
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.